Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

1.2K
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.2K
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy01:26

Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy

584
This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
584
Urodynamic Studies: Uroflowmetry01:19

Urodynamic Studies: Uroflowmetry

7.0K
Uroflowmetry is a non-invasive urodynamic test designed to measure various aspects of urination, including volume, flow rate, and the time to void. This test is crucial for diagnosing and assessing conditions such as bladder outlet obstruction, bladder dysfunction, incomplete bladder emptying, incontinence, and urinary tract blockages caused by benign prostatic hyperplasia (BPH) and urethral strictures.Pre-Test Instructions:Before a uroflowmetry test, patients are typically advised to drink...
7.0K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

1.0K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Government funding for uterine cancer research lags behind rising incidence.

Gynecologic oncology reports·2026
Same author

Characterizing ovarian histopathology in transgender and gender-diverse patients on testosterone: Informing shared decision-making in gender-affirming care.

Frontiers in reproductive health·2026
Same author

Trends in Comparative Growth in Obstetrics and Gynecology Residency Programs Over the Past 20 Years (2005-2024).

Obstetrics and gynecology·2026
Same author

Leveraging Machine Learning and Real-World Data to Predict Chronic Obstructive Pulmonary Disease Exacerbations.

International journal of chronic obstructive pulmonary disease·2025
Same author

Ultrasonography-Based Measurements of Endometrial Thickness in Patients With p53 Abnormal Endometrial Carcinomas.

Obstetrics and gynecology·2025
Same author

Breast cancer and microbiome: a systematic review highlighting challenges for clinical translation.

BMC women's health·2025
Same journal

Response to Letter to the Editor re: "Factors Associated With Persistent Bothersome Urinary Symptoms and Leakage After Pregnancy".

Urogynecology (Philadelphia, Pa.)·2026
Same journal

Methodological Considerations in Postpartum Urinary Incontinence: Addressing Occupational and Clinical Confounders.

Urogynecology (Philadelphia, Pa.)·2026
Same journal

Response to Letter to the Editor re: "Nocturnal Polyuria and MACE: Neuroendocrine Links Explaining Sex Differences" and "Nocturia and Cardiovascular Events: Risk Factor or Clinical Marker?"

Urogynecology (Philadelphia, Pa.)·2026
Same journal

Nocturnal Polyuria and MACE: Neuroendocrine Links Explaining Sex Differences.

Urogynecology (Philadelphia, Pa.)·2026
Same journal

Nocturia and Cardiovascular Events: Risk Factor or Clinical Marker?

Urogynecology (Philadelphia, Pa.)·2026
Same journal

Letter to the Editor re: Using Chatbot to Better Understand What Matters Most to Urogynecologic Patients.

Urogynecology (Philadelphia, Pa.)·2026
See all related articles

Related Experiment Video

Updated: Mar 21, 2026

Real-time fMRI Biofeedback Targeting the Orbitofrontal Cortex for Contamination Anxiety
10:51

Real-time fMRI Biofeedback Targeting the Orbitofrontal Cortex for Contamination Anxiety

Published on: January 20, 2012

21.9K

Home-Based Biofeedback for Fecal Incontinence: A Randomized Clinical Trial.

Ushma J Patel1, Laura E Keyser2, Natalia Gontarczyk Uczkowski3

  • 1Medical College of Wisconsin, Milwaukee, WI.

Urogynecology (Philadelphia, Pa.)
|March 19, 2026
PubMed
Summary
This summary is machine-generated.

An 8-week digital therapeutic pelvic health system is as effective as a 16-week program for treating fecal incontinence (FI) in women. This home-based biofeedback treatment significantly improves FI severity, offering a convenient alternative to traditional therapies.

More Related Videos

The use of Biofeedback in Clinical Virtual Reality: The INTREPID Project
06:52

The use of Biofeedback in Clinical Virtual Reality: The INTREPID Project

Published on: November 12, 2009

15.8K

Related Experiment Videos

Last Updated: Mar 21, 2026

Real-time fMRI Biofeedback Targeting the Orbitofrontal Cortex for Contamination Anxiety
10:51

Real-time fMRI Biofeedback Targeting the Orbitofrontal Cortex for Contamination Anxiety

Published on: January 20, 2012

21.9K
The use of Biofeedback in Clinical Virtual Reality: The INTREPID Project
06:52

The use of Biofeedback in Clinical Virtual Reality: The INTREPID Project

Published on: November 12, 2009

15.8K

Area of Science:

  • Pelvic Health
  • Digital Therapeutics
  • Fecal Incontinence Treatment

Background:

  • Access to biofeedback, a primary treatment for fecal incontinence (FI), is often limited.
  • Home-based digital therapeutic systems offer a potential solution to improve access to FI treatment.

Purpose of the Study:

  • To evaluate the equivalence of an 8-week versus a 16-week duration of a home-based digital therapeutic pelvic health system for treating FI in women.
  • To assess if a shorter treatment duration yields comparable outcomes to a longer duration.

Main Methods:

  • A single-blind, randomized equivalence trial was conducted with women experiencing FI.
  • Participants were assigned to either 8 or 16 weeks of twice-daily exercises using a digital system, with optional remote health coaching.
  • The primary outcome measured was the change in FI severity using the Vaizey score from baseline to 16 weeks.

Main Results:

  • 36 women completed the study, with high adherence (75.2%) to the digital therapeutic system.
  • Both 8-week and 16-week treatment durations resulted in significant improvements in FI severity (Vaizey scores).
  • The 8-week duration was found to be equivalent to the 16-week duration, with changes reaching minimal clinically important differences in both groups (P = 0.918).

Conclusions:

  • A home-based digital pelvic health system utilizing biofeedback and remote coaching effectively improves outcomes for women with FI.
  • Both 8-week and 16-week treatment durations demonstrated significant and equivalent improvements in fecal incontinence severity.
  • Shorter treatment durations of 8 weeks are effective, potentially increasing accessibility to pelvic health interventions.